东阳光药1类丙肝新药获批上市

健识局
10 Feb

近日,据NMPA 官网显示,东阳光药 1 类新药磷酸萘坦司韦胶囊(商品名:东卫卓),该药适用于与艾考磷布韦片联用,治疗初治或干扰素经治的基因1、2、3、6型成人慢性丙型肝炎病毒(HCV)感染,可合并或不合并代偿性肝硬化。根据东阳光药公开资料,磷酸萘坦司韦(曾用名:磷酸安泰他韦)为NS5A抑制剂,艾考磷布韦(曾用名:英强布韦)为NS5B抑制剂,这两款药均为东阳光药自主研发的1类新药。丙型肝炎病毒(...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10